These 10 Companies Led Gains on Wednesday

7. Moderna Inc. (NASDAQ:MRNA)

Pharmaceutical giant Moderna Inc. (MRNA) grew its share prices by 7.27 percent to end at $38.5 apiece after bagging a $590-million deal to develop and accelerate the creation of a bird flu vaccine.

While bird flu used to be more of an agriculture concern, reports said that 66 humans were confirmed to have contracted the flu, with at least one individual succumbing to the virus.

Moderna was previously awarded funds to develop a COVID-19 vaccine and has been struggling to keep its pandemic-era revenue levels.

Moderna’s $590-million deal was on top of the $176 million awarded by the US Department of Health and Human Services to complete the development of a vaccine against H5N1 avian influenza.